Trastuzumab-DM1

ado-trastuzumab emtansine · Genentech (Roche)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Trastuzumab-DM1, covering 2024-12-02 to 2024-12-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study Of Pembrolizumab In Combination With Trastuzumab-DM1 [Phase 1]